AMBALAL SARABHAI ENTERPRISES
Back to Income Statement
|
AMBALAL SARABHAI ENTERPRISES Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹196 Cr | ₹174 Cr | ₹170 Cr | ₹197 Cr | ₹164 Cr |
What is the latest Revenue of AMBALAL SARABHAI ENTERPRISES ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹196 Cr |
| Mar2024 | ₹174 Cr |
| Mar2023 | ₹170 Cr |
| Mar2022 | ₹197 Cr |
| Mar2021 | ₹164 Cr |
How is Revenue of AMBALAL SARABHAI ENTERPRISES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹196 Cr | 13.03 | |
| Mar2024 | ₹174 Cr | 1.93 | |
| Mar2023 | ₹170 Cr | -13.45 | |
| Mar2022 | ₹197 Cr | 20.23 | |
| Mar2021 | ₹164 Cr | - | |
Compare Revenue of peers of AMBALAL SARABHAI ENTERPRISES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AMBALAL SARABHAI ENTERPRISES | ₹203.6 Cr | -7% | 1.9% | -44.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹411,054.0 Cr | 0.9% | 6.2% | -1.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,075.0 Cr | 2% | 4.8% | 4.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,904.0 Cr | 3.6% | 6% | 36.9% | Stock Analytics | |
| CIPLA | ₹107,358.0 Cr | -0.1% | -3% | -8.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,813.0 Cr | 1% | 10.8% | 4.7% | Stock Analytics | |
AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AMBALAL SARABHAI ENTERPRISES | -7% |
1.9% |
-44.3% |
| SENSEX | -1.4% |
0.4% |
8.3% |
You may also like the below Video Courses